reconstituted: refrigerate at 28 C (35.646.4 F) and use within 30 days
GLP-1 medications such as Ozempic, Wegovy, Mounjaro, and Zepbound are increasingly popular for weight loss and diabetes management
As patents expire and potential generic or biosimilar versions emerge (e.g., generic liraglutide by Teva in 2024 ( [68] )), costs might come down, but for newer agents like semaglutide or tirzepatide, it could be years
Following this, secondary antibodies were applied at room temperature and incubated for 1 hour, followed by 4,6-diamidino-2-phenylindole (DAPI) for 5 minutes
Tirzepatide (Mounjaro, Zepbound) is a related but distinct medication that acts as a dual glucose-dependent insulinotropic polypeptide (GIP) and GLP-1 receptor co-agonist
Faster loss means a deeper deficit, and a deeper deficit is harder on lean tissue